NOVELION THERAPEUTICS
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.
NOVELION THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1981-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.novelion.com
Total Employee:
251+
Status:
Active
Contact:
604.707.7000
Email Addresses:
[email protected]
Total Funding:
72 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 GoDaddy DNS Amazon Virginia Region OVH Mimecast Akamai Hosted
Similar Organizations
Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-06-15 | Aegerion Pharmaceuticals | Aegerion Pharmaceuticals acquired by Novelion Therapeutics | N/A |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Novelion Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-06-08 | Aralez Pharmaceuticals | Novelion Therapeutics investment in Post-IPO Equity - Aralez Pharmaceuticals | 350 M USD |
Official Site Inspections
http://www.novelion.com
- Host name: ec2-107-22-175-16.compute-1.amazonaws.com
- IP address: 107.22.175.16
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Novelion Therapeutics"
Novelion Therapeutics Inc. | Alvarez & Marsal - Alvarez and Marsal
Jan 16, 2020 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Announces Completion of Plan of Liquidation and …
Mar 10, 2023 The final distribution was comprised of approximately US$2.47 million (US$0.125/share), representing the aggregate of the cash remaining in Novelion, including the …See details»
Novelion Announces Completion of Plan of Liquidation and
Mar 10, 2023 Shareholders whose shares in Novelion were held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Announces Completion of Plan of Liquidation and …
Mar 10, 2023 Shareholders whose shares in Novelion were held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Provides Update on Final Distribution to Registered …
Jun 28, 2021 VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s …See details»
Novelion Therapeutics Inc. - AnnualReports.com
Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of …See details»
Novelion Therapeutics - Crunchbase Company Profile & Funding
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with …See details»
Novelion Therapeutics Provides Update on Liquidation Process
Sep 30, 2020 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Therapeutics Inc. - Press Release | Alvarez & Marsal ...
Novelion Provides Update on Final Distribution to Registered Shareholders. Access all Engagement updates and court filed materials for all active engagements in which either …See details»
Novelion Therapeutics Inc (NVLNF) Profile - The Globe and Mail
See the company profile for Novelion Therapeutics Inc (NVLNF) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Novelion Therapeutics Provides Update on Liquidation Process
Sep 30, 2020 Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s court appointed liquidator (the “Liquidator”) today provides an update …See details»
Novelion Provides Update on Final Distribution to Registered ...
Jun 28, 2021 VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) — Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., …See details»
Novelion Announces Date of Final Distribution to Registered
Mar 28, 2022 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Announces Date of Interim Distribution to Registered …
Mar 4, 2021 VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s …See details»
Novelion Therapeutics Provides Update on Liquidation
Sep 30, 2020 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Announces Date of Final Distribution to Registered …
Mar 28, 2022 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Announces Court Approval for Interim Distribution
Dec 23, 2020 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Announces Date of Interim Distribution to Registered ...
Mar 4, 2021 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Announces Date of Interim Distribution to
Mar 4, 2021 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»
Novelion Provides Update on Interim Distribution to Registered ...
Jan 26, 2021 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»